Farkas Á - Search Results

1

[Health effects of cigarettes, electronic cigarettes and waterpipes].

Farkas Á, Tomisa G, Kis E, Horváth A. Farkas Á, et al. Orv Hetil. 2021 Jan 17;162(3):83-90. doi: 10.1556/650.2021.32079. Orv Hetil. 2021. PMID: 33459608 Hungarian.

2

Alpha-hit, cellular dose, cell transformation and inactivation probability distributions of radon progenies in the bronchial epithelium.

Szoke I, Balásházy I, Farkas A, Hofmann W, Szoke R, Fakir H, Kis E. Szoke I, et al. Among authors: farkas a. Radiat Prot Dosimetry. 2006;122(1-4):540-2. doi: 10.1093/rpd/ncl428. Epub 2006 Dec 4. Radiat Prot Dosimetry. 2006. PMID: 17145731

3

Simulation and minimisation of the airway deposition of airborne bacteria.

Balásházy I, Horváth A, Sárkány Z, Farkas A, Hofmann W. Balásházy I, et al. Among authors: farkas a. Inhal Toxicol. 2009 Oct;21(12):1021-9. doi: 10.1080/08958370902736646. Inhal Toxicol. 2009. PMID: 19772481

4

Quantification of airway deposition of intact and fragmented pollens.

Horváth A, Balásházy I, Farkas A, Sárkány Z, Hofmann W, Czitrovszky A, Dobos E. Horváth A, et al. Among authors: farkas a. Int J Environ Health Res. 2011 Dec;21(6):427-40. doi: 10.1080/09603123.2011.574269. Epub 2011 May 23. Int J Environ Health Res. 2011. PMID: 21563012

5

Computer modeling of airway deposition distribution of Foster(®) NEXThaler(®) and Seretide(®) Diskus(®) dry powder combination drugs.

Jókay Á, Farkas Á, Füri P, Horváth A, Tomisa G, Balásházy I. Jókay Á, et al. Among authors: farkas a. Eur J Pharm Sci. 2016 Jun 10;88:210-8. doi: 10.1016/j.ejps.2016.03.008. Epub 2016 Mar 11. Eur J Pharm Sci. 2016. PMID: 26976481

6

Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort(®) Turbuhaler(®) dry powder fixed combination aerosol drug.

Farkas Á, Jókay Á, Balásházy I, Füri P, Müller V, Tomisa G, Horváth A. Farkas Á, et al. Eur J Pharm Sci. 2016 Oct 10;93:371-9. doi: 10.1016/j.ejps.2016.08.036. Epub 2016 Aug 21. Eur J Pharm Sci. 2016. PMID: 27552906

7

Significance of breath-hold time in dry powder aerosol drug therapy of COPD patients.

Horváth A, Balásházy I, Tomisa G, Farkas Á. Horváth A, et al. Among authors: farkas a. Eur J Pharm Sci. 2017 Jun 15;104:145-149. doi: 10.1016/j.ejps.2017.03.047. Epub 2017 Apr 4. Eur J Pharm Sci. 2017. PMID: 28389274

8

Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler^® dry powder inhaler.

Farkas Á, Lewis D, Church T, Tweedie A, Mason F, Haddrell AE, Reid JP, Horváth A, Balásházy I. Farkas Á, et al. Int J Pharm. 2017 Nov 25;533(1):225-235. doi: 10.1016/j.ijpharm.2017.09.057. Epub 2017 Sep 21. Int J Pharm. 2017. PMID: 28941830 Free article.

9

Effect of delayed pMDI actuation on the lung deposition of a fixed-dose combination aerosol drug.

Farkas Á, Horváth A, Kerekes A, Nagy A, Kugler S, Tamási L, Tomisa G. Farkas Á, et al. Int J Pharm. 2018 Aug 25;547(1-2):480-488. doi: 10.1016/j.ijpharm.2018.06.016. Epub 2018 Jun 7. Int J Pharm. 2018. PMID: 29886099

10

Simulation of Airway Deposition of an Aerosol Drug in COPD Patients.

Farkas Á, Lizal F, Jedelsky J, Elcner J, Horváth A, Jicha M. Farkas Á, et al. Pharmaceutics. 2019 Apr 1;11(4):153. doi: 10.3390/pharmaceutics11040153. Pharmaceutics. 2019. PMID: 30939795 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

951 results

Search Page

Filters